Our
Leadership

Bio: Steve, appointed as Executive Chairman in June 2023 after working for five years as Chief Executive Officer, has worked for NorthStar since March 2016. He has more than 30 years of experience in the biotechnology, pharmaceutical and life sciences industries. He has held multiple executive positions with leading multinational companies, including leadership of nuclear medicine businesses. Steve has extensive general management and corporate officer experience, and a proven record of accomplishment with integrating science, engineering and commercial activities to drive complex projects to successful completion. Steve also served in the Royal Navy as a Nuclear Submarine Officer, where he specialized in Navigation and Operations.

Education: Steve received a BSc (Honors) in Engineering Science from the University of Exeter and an MBA from the London Business School, both in the United Kingdom. He also completed the Nuclear General Course at the Royal Naval Staff College, Greenwich in the United Kingdom.

Bio: Frank, appointed as NorthStar’s President and Chief Executive Officer in June 2023, has more than 25 years of global experience in the pharmaceutical and life sciences industries as well as in consulting. He has held executive-level positions in general management, operations, quality, alliance management, and merger integration. Frank has led transformative change throughout the value chain of pharmaceutical companies, and managed multiple acquisitions and divestitures in branded pharmaceuticals, generics, and medical device assets. Before joining NorthStar, Frank was a Managing Director with AlixPartners, the Chief Operations Officer and Chief Digital Innovation Officer at Mallinckrodt Pharmaceuticals, and a Partner with McKinsey & Company.

Education: Frank holds a Ph.D. in Business Management from the University of Bielefeld, Germany, an MBA from the Georgetown University McDonough School of Business in Washington D.C., and a Master’s in Economics from the Leibniz University of Hannover, Germany.

Bio: Paul brings more than 30 years of relevant experience to NorthStar where he is responsible for the Financial operations of the company.  Prior to NorthStar, he was the CFO of Melinta Therapeutics, Inc., a publicly traded company focused on the discovery, development and commercialization of novel antibiotics.  During his five-year tenure at Melinta, Paul guided the company in the process of converting from a private to public enterprise, raised more than $500 million in support of the company, assisted in the acquisition of products from other companies, facilitated a merger and supported the commercial launch of multiple products.  Prior to Melinta, he spent more than 20 years with Baxter International, Inc. where he held both financial and non-financial positions of increasing responsibility. During his tenure at Baxter, his experiences included divisional CFO for various divisions of Baxter, CFO of Baxter’s operations in Japan and serving as the Vice-President of Integration for a large acquisition.  Prior to Baxter, Paul was a public accountant with Arthur Andersen & Co.

Education: Paul earned a Master of Business Administration degree from the Kellogg School of Management at Northwestern University and a Bachelor of Science degree in Accounting from Illinois State University.

Bio: Jim has more than 40 years of design and management experience in the areas of scientific development and business operations.  His operational responsibilities have included leadership of laboratory operations in nuclear and mixed waste areas and environmental services.  While involved in technology start-up companies, Jim has also been responsible for manufacturing, developing quality assurance programs for compliance to Nuclear Regulatory Commission and Department of Energy requirements, managing company activities to ensure compliance with federal and state regulations, and managing major government contracts involving federal research and development programs.  He also served as a commissioned officer in the US Air Force in control of ballistic missiles, and has invented or co-invented several patented technologies.

Education: Jim received a BS in Chemistry from the University of Virginia and a Ph.D. in Nuclear Chemistry from the University of Arkansas.

Bio: Jeff joined NorthStar with more than 40 years of experience in the pharmaceutical industry. Jeff is responsible for Operations, Quality, execution of strategic projects, the start-up and product development of the NorthStar CDMO operation, managing site security, facility support, maintenance, IT and new facility construction. Jeff’s experience prior to joining NorthStar included roles in manufacturing operations, quality, corporate engineering, distribution/support of drug/device combinations, M&A, IT, enterprise system strategies, capital funding management and program/project management at companies such as Aventis, Wyeth, Pfizer, Merck, Mallinckrodt and Hill-Rom.

Education: Jeff has a Bachelor of Science degree with a business minor from the University of Louisville.

Bio: Monica brings more than 30 years of Human Resource leadership experience to NorthStar. Prior to NorthStar, Monica spent over a decade with Covidien and Mallinckrodt Pharmaceuticals where she served as the HR leader of the Specialty Generics business. During her tenure, Monica provided HR leadership to various initiatives at Mallinckrodt including support for M&A, integration, organizational design, labor and employee relations, talent and performance management, HR policies and benefits and rewards programs. Prior to Covidien, Monica significantly contributed to the successful spin-off of Western Union from First Data Corporation and led strategic and transformative business initiatives leveraging her global employee and labor relations expertise. Monica’s leadership experience in Human Resources spans industries and blue-chip companies including GE Industrial Systems, GE Capital, NCH Promotional Services and A. C. Nielsen, both previous divisions of Dun & Bradstreet.

Education: Monica holds a Master’s in Labor and Industrial Relations from the University of Illinois, Urbana-Champaign and a B.A. in Psychology, Sociology and Anthropology from North Central College in Naperville, Illinois

Bio: Jean-Noel, appointed as NorthStar’s Vice President of Operations in April 2023, has more than 25 years of global experience in the automotive, pharmaceutical and life sciences industries as well as in consulting. He has held various level positions in general management, operations, quality, IT, supply chain and merger integration. Jean-Noel has led transformative change, network optimizations and managed multiple acquisitions in branded pharmaceuticals and generics, assets. Before joining NorthStar, Jean-Noel was the Vice President Transformation within the Cell and Gene Therapy business at Catalent, Managing Director of Seqens CDMO North America, and a General Manager with Patheon Pharmaceuticals.

Education: Jean-Noel holds an MBA from Emory Business School and an MS in Mechanical Engineering from the Ecole Nationale Superieure de Techniques Avancees in Paris.

Bio: Alison brings more than 20 years of finance and operations management leadership experience to NorthStar. She has been a leader of the Company’s finance team since 2017, and assumed the role of Chief of Staff in September 2023. Prior to joining NorthStar, she spent her career in the automotive and distribution industries, holding various leadership positions with experience in finance, management, corporate tax, investor relations, operations, IT, and capital management.

Education: Alison has a Master of Business Administration degree with an Accounting emphasis from Davenport University, and a Bachelor of Business Administration degree in Finance from University of Wisconsin-Whitewater.

Bio: Adam, appointed as NorthStar’s Vice President of Finance and External Affairs in September 2023, has more than 20 years of experience in the healthcare industry. He understands healthcare from a provider’s perspective by having led accreditation renewal efforts and by managing GPO contracting. He was instrumental in managing a community hospital’s initial and second wave Pandemic response in 2020. Adam’s familiarity with healthcare drivers stems from the collaborative approach he has taken to accomplish key strategic objectives such as obtaining critical COVID-19 test kits, procuring PPE, decompressing inpatient occupancy, and securing millions in committed capital. Before joining NorthStar, Adam was interim Chief Financial Officer with Humboldt Park Health, a Group Vice President with Illinois Health and Hospital Association, and Vice President at Principle Valuation and Citadel Group Limited, respectively.

Education: Adam holds a Bachelor of Science degree in Real Estate and Finance from the University of Wisconsin – Milwaukee and is a former Visiting Lecturer at Loyola University’s Health Law Institute in Chicago, IL.

Bio: Rob has 29 years of experience encompassing roles in quality, manufacturing, and research and development at in-vitro diagnostic, medical device, and pharmaceutical companies. He comes to NorthStar from Avantor, where he was the Vice President of Quality and Compliance Systems and Services. Before that, he served as the Director, Global Quality Risk Management at Thermo Fisher Scientific. Prior to joining Thermo Fisher Scientific, he worked for AbbVie, Pricewaterhouse Coopers, Pfizer, Baxter, and Abbott Laboratories.

Education: Rob earned a Bachelor of Science degree in Biology from the University of Wisconsin – Stevens Point.

Bio: Jason joined NorthStar with more than 22 years of experience specific to the radioisotope and radiopharmaceutical industry. His career has consisted of both operational and commercial roles. Operational responsibilities included facility management for isotope production with Regional Nuclear Pharmaceuticals (now Cardinal Health). His career progressed into the commercial side where he held five different roles of increasing responsibility over sixteen years with Mallinckrodt/Curium. His most recent role prior to joining NorthStar was Global Director of Business Development for Curium’s Active Pharmaceutical Ingredient business as well as a responsibility for a considerable portion of their US SPECT franchise.

Education: Jason holds a Masters in Business Administration and a Masters in Healthcare Administration from the University of St. Francis in Joliet, IL and a Bachelor of Science degree from Jacksonville State University.

Bio: Dave brings 30 years of radiopharmaceutical manufacturing leadership experience to NorthStar.  His expertise in creating and implementing successful operational programs in rapidly growing radiopharmaceutical businesses provides a valuable resource for the Company.  Prior to joining NorthStar, Dave was Vice President, PET & SPECT Pharmacy Operations for Triad Isotopes, where he oversaw daily operations of its southeastern U.S. radiopharmacies.  In addition, he led all its PET manufacturing sites through several FDA approvals, including F-18 FDG and F-18 NaF.  Previously, while at PETNET Solutions, a Siemens company, Dave led multi-disciplinary teams in a dynamic growth environment to establish new PET isotope manufacturing centers across the United States.  Dave’s ability to effectively lead diverse functional teams, in addition to his financial skills focused on operational efficiency, are a welcome addition to the NorthStar management team.

Education: Dave is a Board Certified Nuclear Pharmacist and holds a Bachelor of Science in Pharmacy from the St Louis College of Pharmacy.